NSC |
Compound |
Enrichment |
Correlation |
NSC 711611 |
Null |
0.0102962192514438 |
0.36119333 |
NSC 718728 |
5-[2-(2,5-Dimethoxyphenyl)ethynyl]-2-methoxyphenyl-N- [2-(4-fluorophenyl)ethyl]carboxamide |
0.0102962192514438 |
0.37868239 |
NSC 724631 |
4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione |
0.0102962192514438 |
0.31198058 |
NSC 737613 |
Null |
0.0102962192514438 |
0.33998739 |
NSC 740385 |
7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide |
0.0102962192514438 |
0.41594732 |
NSC 128571 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) |
0.0102962192514439 |
0.20283028 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.0102962192514439 |
0.19146653 |
NSC 205555 |
Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- |
0.0102962192514439 |
0.20499198 |
NSC 22348 |
1H-Naphth[2,3-d]imidazole-4,9-dione, 1-(p-bromophenyl)- 2-methyl- |
0.0102962192514439 |
0.36799981 |
NSC 26074 |
Null |
0.0102962192514439 |
0.43225752 |